The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Dexatrim     (1R,2R)-2-amino-1-phenyl- propan-1-ol

Synonyms: Cathinum, Exponcit, Mucorama, Naldecon, Snaplets, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Norephedrine


Psychiatry related information on Norephedrine


High impact information on Norephedrine


Chemical compound and disease context of Norephedrine


Biological context of Norephedrine


Anatomical context of Norephedrine


Associations of Norephedrine with other chemical compounds


Gene context of Norephedrine


Analytical, diagnostic and therapeutic context of Norephedrine


  1. Toxicity of over-the-counter stimulants. Pentel, P. JAMA (1984) [Pubmed]
  2. Use of nonprescription weight loss products: results from a multistate survey. Blanck, H.M., Khan, L.K., Serdula, M.K. JAMA (2001) [Pubmed]
  3. Acute renal failure and rhabdomyolysis after ingestion of phenylpropanolamine-containing diet pills. Swenson, R.D., Golper, T.A., Bennett, W.M. JAMA (1982) [Pubmed]
  4. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment. Biaggioni, I., Onrot, J., Stewart, C.K., Robertson, D. JAMA (1987) [Pubmed]
  5. Pseudopheochromocytoma and cardiac arrest associated with phenylpropanolamine. Hyams, J.S., Leichtner, A.M., Breiner, R.G., Hill, D.W., McComb, R.B., Manger, W.M. JAMA (1985) [Pubmed]
  6. Affective disorder following use of phenylpropanolamine. Grieger, T.A., Clayton, A.H., Goyer, P.F. The American journal of psychiatry. (1990) [Pubmed]
  7. The effects of phenylpropanolamine on dietary intake, physical activity, and body weight after smoking cessation. Klesges, R.C., Klesges, L.M., Meyers, A.W., Klem, M.L., Isbell, T. Clin. Pharmacol. Ther. (1990) [Pubmed]
  8. Phenylpropanolamine OROS (Acutrim) vs. placebo in combination with caloric restriction and physician-managed behavior modification. Weintraub, M., Ginsberg, G., Stein, E.C., Sundaresan, P.R., Schuster, B., O'Connor, P., Byrne, L.M. Clin. Pharmacol. Ther. (1986) [Pubmed]
  9. Overview of adrenergic anorectic agents. Wellman, P.J. Am. J. Clin. Nutr. (1992) [Pubmed]
  10. Catatonia associated with phenylpropanolamine overdose and fluphenazine treatment: case report. Castellani, S. The Journal of clinical psychiatry. (1985) [Pubmed]
  11. Renal failure, rhabdomyolysis, and phenylpropanolamine. Blewitt, G.A., Siegel, E.B. JAMA (1983) [Pubmed]
  12. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. Lake, C.R., Gallant, S., Masson, E., Miller, P. Am. J. Med. (1990) [Pubmed]
  13. Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin. Lee, K.Y., Beilin, L.J., Vandongen, R. Lancet (1979) [Pubmed]
  14. Cerebral hemorrhage associated with phenylpropanolamine in combination with caffeine. Mueller, S.M., Muller, J., Asdell, S.M. Stroke (1984) [Pubmed]
  15. Propranolol antagonism of phenylpropanolamine-induced hypertension. Pentel, P.R., Asinger, R.W., Benowitz, N.L. Clin. Pharmacol. Ther. (1985) [Pubmed]
  16. Blinding, unblinding, and the placebo effect: an analysis of patients' guesses of treatment assignment in a double-blind clinical trial. Moscucci, M., Byrne, L., Weintraub, M., Cox, C. Clin. Pharmacol. Ther. (1987) [Pubmed]
  17. Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity. Greenway, F., Herber, D., Raum, W., Herber, D., Morales, S. Obes. Res. (1999) [Pubmed]
  18. Phenylpropanolamine and blood pressure. Lasagna, L. JAMA (1985) [Pubmed]
  19. Effect of phenylpropanolamine on energy expenditure and weight loss in overweight women. Alger, S., Larson, K., Boyce, V.L., Seagle, H., Fontvieille, A.M., Ferraro, R.T., Rising, R., Ravussin, E. Am. J. Clin. Nutr. (1993) [Pubmed]
  20. Postpartum intracranial hemorrhage and phenylpropanolamine use. Maher, L.M., Peterson, P.L., Dela-Cruz, C. Neurology (1987) [Pubmed]
  21. Effects of chronic phenylpropanolamine infusion and termination on body weight, food consumption and water consumption in rats. Winders, S.E., Amos, J.C., Wilson, M.R., Rushing, P.A., Dykstra, T., Coday, M.C. Psychopharmacology (Berl.) (1994) [Pubmed]
  22. A novel enantioselective alkylation and its application to the synthesis of an anticancer agent. Kuo, S.C., Chen, F., Hou, D., Kim-Meade, A., Bernard, C., Liu, J., Levy, S., Wu, G.G. J. Org. Chem. (2003) [Pubmed]
  23. The effects of phenylpropanolamine on human sympathetic nervous system function. Lake, C.R., Chernow, B., Zaloga, G., Labow, J., Quirk, R., Hedges, S.M. Neuropsychopharmacology (1988) [Pubmed]
  24. Open-channel block by internally applied amines inhibits activation gate closure in batrachotoxin-activated sodium channels. Zamponi, G.W., French, R.J. Biophys. J. (1994) [Pubmed]
  25. Neutral and anionic cyclodextrins in capillary zone electrophoresis: enantiomeric separation of ephedrine and related compounds. Dette, C., Ebel, S., Terabe, S. Electrophoresis (1994) [Pubmed]
  26. Phenylpropanolamine constricts mouse and human blood vessels by preferentially activating alpha2-adrenoceptors. Flavahan, N.A. J. Pharmacol. Exp. Ther. (2005) [Pubmed]
  27. A pharmacodynamic interaction between caffeine and phenylpropanolamine. Brown, N.J., Ryder, D., Branch, R.A. Clin. Pharmacol. Ther. (1991) [Pubmed]
  28. Pharmacodynamics and pharmacokinetics of khat: a controlled study. Widler, P., Mathys, K., Brenneisen, R., Kalix, P., Fisch, H.U. Clin. Pharmacol. Ther. (1994) [Pubmed]
  29. Enantioselectivity of basic analytes in CZE enantioseparation under reversed-polarity mode using sulfated beta-cyclodextrins as chiral selectors: An unusual temperature effect. Lin, C.H., Kuo, C.M., Liu, Y.C., Cheng, H.T., Lin, W.Y., Wu, J.C., Wang, L.F., Lin, C.E. Electrophoresis (2006) [Pubmed]
  30. N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine. Altenbach, R.J., Khilevich, A., Meyer, M.D., Buckner, S.A., Milicic, I., Daza, A.V., Brune, M.E., O'Neill, A.B., Gauvin, D.M., Cain, J.C., Nakane, M., Holladay, M.W., Williams, M., Brioni, J.D., Sullivan, J.P. J. Med. Chem. (2002) [Pubmed]
  31. Terfenadine with or without phenylpropanolamine in the treatment of seasonal allergic rhinitis. Nuutinen, J., Holopainen, E., Malmberg, H., Rinne, J., Suonpää, J., Silvasti, M. Clin. Exp. Allergy (1989) [Pubmed]
  32. Effects of the alpha 1a-adrenoceptor antagonist RS-17053 on phenylpropanolamine-induced anorexia in rats. Wellman, P.J., McMahon, L.R., Green, T., Tole, A. Pharmacol. Biochem. Behav. (1997) [Pubmed]
  33. Cardiomyopathy induced by phenylpropanolamine. Chin, C., Choy, M. J. Pediatr. (1993) [Pubmed]
  34. Pharmacokinetics of the orally administered decongestants pseudoephedrine and phenylpropanolamine in children. Simons, F.E., Gu, X., Watson, W.T., Simons, K.J. J. Pediatr. (1996) [Pubmed]
  35. Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression. Hsieh, Y.S., Hsu, J.D., Yang, S.F., Kuo, D.Y. Peptides (2004) [Pubmed]
  36. Dyskinesias possibly induced by norpseudoephedrine. Thiel, A., Dressler, D. J. Neurol. (1994) [Pubmed]
  37. Phenylpropanolamine exposure and subsequent hospitalization. Aselton, P., Jick, H., Hunter, J.R. JAMA (1985) [Pubmed]
  38. Cerebral vasculitis and hemorrhage associated with phenylpropanolamine. Fallis, R.J., Fisher, M. Neurology (1985) [Pubmed]
WikiGenes - Universities